Fcpm III Services B.v.
Annual return '25
-11.2%
SPY '25
+17.7%
Alpha
-28.9ptsvs SPY
Invested
$722.2M
Holdings
10
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$NAMS
NEWAMSTERDAM PHARMA COMPANY
Held since at least Q1 2024
40.8%
02
$DYN
DYNE THERAPEUTICS INC
Held since at least Q1 2024
11.7%
03
$VOR
VOR BIOPHARMA INC
Held since at least Q1 2024
10.2%
04
$ENGN
ENGENE HOLDINGS INC
Held since at least Q1 2024
9.1%
05
$MPLT
MAPLIGHT THERAPEUTICS INC
Held since at least Q1 2024
9.1%
06
$DMRA
DAMORA THERAPEUTICS INC
Held since at least Q1 2024
8.8%
07
$CBIO
CRESCENT BIOPHARMA INC.
Held since at least Q1 2024
4.3%
08
$REPL
REPLIMUNE GROUP INC
Held since at least Q1 2024
3.0%
09
$BCYC
BICYCLE THERAPEUTICS PLC
Held since at least Q1 2024
2.2%
10
$ENGNW
ENGENE HOLDINGS INC
Held since at least Q1 2024
1.0%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 09:44 UTC.